DRUGS FOR ISCHEMIC HEART DISEASE Textbook notes

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/18

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

19 Terms

1
New cards

What is the focus of pharmacologic management for ischemic heart disease?

It focuses on appropriate management for each stage—angina relief vs mortality benefit.

2
New cards

Which drug class is first-line for chronic stable angina?

β-Blockers.

3
New cards

How do nitrates work to relieve angina?

They release nitric oxide, activating guanylate cyclase, increasing cGMP, which relaxes vascular smooth muscle and improves coronary flow.

4
New cards

What is the mechanism of action for β-blockers?

They antagonize β₁-receptors, reducing heart rate, contractility, and blood pressure, thereby lowering myocardial oxygen demand and infarct risk.

5
New cards

What condition are β-blockers contraindicated in?

Vasospastic (variant) angina.

6
New cards

What are dihydropyridines used for in ischemic heart disease?

They provide vascular dilation.

7
New cards

Which drugs block L-type Ca²⁺ channels?

Calcium Channel Blockers (CCBs).

8
New cards

What is the purpose of ranolazine in ischemic heart disease management?

It reduces late Na⁺ current to improve diastolic function and is used as an add-on or β-blocker alternative.

9
New cards

What side effects can β-blockers cause in diabetics?

They may mask hypoglycemia.

10
New cards

What is the recommended treatment for acute ischemia?

Short-acting nitrates and a β-blocker.

11
New cards

Which drugs can be combined with β-blockers if symptoms persist?

Calcium channel blockers or long-acting nitrates.

12
New cards

What is ivabradine used for?

It lowers heart rate without affecting blood pressure or contractility.

13
New cards

What is the significance of nitrates developing tolerance?

Tolerance can develop, requiring strategies like daily nitrate-free intervals.

14
New cards

What risks are associated with the use of calcium channel blockers?

Hypotension, edema, and constipation (especially with verapamil).

15
New cards

What are the vital agents for secondary prevention post-acute events?

Antiplatelets (aspirin, P2Y₁₂ inhibitors) and statins.

16
New cards

What is the potential downside of using ranolazine?

It may cause QT prolongation.

17
New cards

How do nitrates affect coronary flow?

By reducing preload through vascular smooth muscle relaxation.

18
New cards

What is the goal heart rate when titrating treatments for ischemic heart disease?

Approximately 55–60 bpm.

19
New cards

What are “Opiegram summaries” used for?

They illustrate mechanisms and comparative drug profiles for efficient learning.